Hydroxyurea in the management of sickle cell disease: pharmacogenomics and enzymatic metabolism-Reference-Cited by-同舟云学术

Hydroxyurea in the management of sickle cell disease: pharmacogenomics and enzymatic metabolism

Published:2018-09-12 Issue:6 Volume:18 Page:730-739
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Yahouédéhou Sètondji Cocou Modeste Alexandre,Adorno Elisângela Vitória,da Guarda Caroline Conceição,Ndidi Uche Samuel,Carvalho Suellen Pinheiro,Santiago Rayra Pereira,Aleluia Milena Magalhães,de Oliveira Rodrigo Mota,Gonçalves Marilda de Souza

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/s41397-018-0045-1.pdf

Reference66 articles.

1. Villani P, Maserati R, Regazzi MB, Giacchino R, Lori F. Pharmacokinetics of hydroxyurea in patients infected with human immunodeficiency virus type I. J Clin Pharmacol. 1996;36:117–21.

2. Opacic N, Zorc B, Cetina M, Mrvos-Sermek D, Raic-Malic S, Mintas M. Synthesis and X-ray crystal structure study of the hydroxyurea and hydantoin derivatives of l-valine. J Pept Res. 2005;66:85–93.

3. Dalton RN, Turner C, Dick M, Height SE, Awogbade M, Inusa B, et al. The measurement of urinary hydroxyurea in sickle cell anaemia. Br J Haematol. 2005;130:138–44.

4. Latagliata R, Spadea A, Cedrone M, Di Giandomenico J, De Muro M, Villivà N, et al. Gruppo Laziale SMPC Ph1 neg. Symptomatic mucocutaneous toxicity of hydroxyurea in Philadelphia chromosome-negative myeloproliferative neoplasms: the Mister Hyde face of a safe drug. Cancer . 2012;118:404–9.

5. Lori F, Lisziewicz J. Rationale for the use of hydroxyurea as an anti-human immunodeficiency virus drug. Clin Infect Dis. 2000;30:S193–7.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sickle Cell Disease: Current Drug Treatments and Functional Foods with Therapeutic Potential;Current Issues in Molecular Biology;2024-06-12

2. Hydroxyurea attenuates hepatic stellate cell proliferation in vitro and liver fibrogenesis in vivo;The FASEB Journal;2023-08-08

3. Effectiveness of Pharmacokinetic-Guided Hydroxyurea Dose Individualization in Patients with Sickle Cell Anemia: A Mini-Review;Pharmaceuticals;2023-06-08

4. Are Genetic Modifiers the Answer to Different Responses to Hydroxyurea Treatment?—A Pharmacogenetic Study in Sickle Cell Anemia Angolan Children;International Journal of Molecular Sciences;2023-05-15

5. The effect of hydroxyurea response on gut microbiota of beta-thalassemia major patients;2023-04-12